← Every applicant
Navinta LLC FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| GLYCEROL PHENYLBUTYRATENew drugApr 23, 2026LIQUID, ORAL |
| SODIUM PHENYLBUTYRATENew drugFeb 17, 2026TABLET, ORAL |
| DIAZEPAMNew drugNov 14, 2025GEL, RECTAL |
| SEVELAMER CARBONATENew drugOct 27, 2025TABLET, ORAL |
| MARAVIROCNew drugMay 13, 2025TABLET, ORAL |
| MIGLUSTATNew drugMar 14, 2025CAPSULE, ORAL |
| SEVELAMER HYDROCHLORIDENew drugFeb 3, 2025TABLET, ORAL |
| SODIUM PHENYLACETATE AND SODIUM BENZOATENew drugJul 14, 2023SOLUTION, INTRAVENOUS |
| CARGLUMIC ACIDNew drugJun 22, 2022TABLET, FOR SUSPENSION, ORAL |
| PENICILLAMINENew drugOct 8, 2021CAPSULE, ORAL |